Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Rossana Berardi
Observed names:
Berardi, Rossana,
R. Berardi
Institutions:
Marche Polytechnic University,
Azienda Ospedaliero-Universitaria delle Marche
Observed institutions:
Marche Polytechnic University,
Azienda Ospedaliero-Universitaria delle Marche
ORCID:
0000-0002-9529-2960
Observed ORCID:
0000-0002-9529-2960
OpenAlex ID:
A5027292048
Corrigendum to ‘The lung immuno-oncology prognostic score (LIPS-3): a prognostic classification of patients receiving first-line pembrolizumab for PD-L1 ≥ 50% advanced non-small-cell lung cancer’
2021
·
G.L. Banna
, A. Cortellini
, et al.
·
ESMO Open
·
4
Predictive biomarkers for cetuximab-based rechallenge therapy in metastatic colorectal cancer: a pooled analysis of the CAVE and CAVE-2 GOIM studies
2026
·
D. Ciardiello
, G. Martini
, et al.
·
ESMO Gastrointestinal Oncology
·
2
The role of the molecular tumor board: learnings from the ROME trial
2026
·
P. Marchetti
, G. Curigliano
, et al.
·
npj Precision Oncology
·
2
PDF
Cardiotoxicity of Antitumor Agents: Therapeutic Challenges in Heart Failure with Reduced and Preserved Ejection Fraction
2026
·
Marco Tana
, Rachele Piccinini
, et al.
·
International Journal of Molecular Sciences
·
2
PDF
Metformin impact on progression-free survival in diabetic patients with advanced pancreatic neuroendocrine tumors (pNET) receiving everolimus and/or somatostatin analogues. The PRIME-NET (Pancreatic multicentric, Retrospective, Italian MEtformin) study
2016
·
S. Pusceddu
, R. Marconcini
, et al.
·
Annals of Oncology
·
2
Real-world presentation and outcomes of gastroenteropancreatic neuroendocrine neoplasms in Italy: findings from the nationwide Itanet prospective database
2026
·
Francesco Panzuto
, Maria Rinzivillo
, et al.
·
The Lancet Regional Health - Europe
·
1
1870P Progesterone receptor and visceral conversion in bone-only HR+/HER2-negative metastatic breast cancer
2026
·
R. Scafetta
, A. Botticelli
, et al.
·
Annals of Oncology
554P Body mass index and pathological complete response in early stage and locally advanced HER2-positive and triple negative breast cancer patients: Preliminary results from the GIM 28-ELMER study
2026
·
L. Carbognin
, A. Meacci
, et al.
·
Annals of Oncology
4183P Temporal trends in presentation, management and outcomes of surgically treated thymic epithelial tumors: Evidence from the Italian TYME Network
2026
·
G. Leuzzi
, F. Sabia
, et al.
·
Annals of Oncology
3663eP CABOzantinib therapy outcomes and GENomic profiling in metastatic renal cell carcinoma (mRCC) patients (pts): The results of CABOGEN study
2026
·
C. Masini
, E. Borghi
, et al.
·
Annals of Oncology
Cholesterol transporters and immune-metabolic features in patients with metastatic renal cell carcinoma receiving immunotherapy combinations
2026
·
Giulia Claire Giudice
, Hassan Mohammed Abushukair
, et al.
·
The Oncologist
PDF
194P LLM-generated narratives improve oncologists' understanding of AI-based immunotherapy response prediction in metastatic NSCLC
2026
·
C.M. Licciardello
, G. Di Virgilio
, et al.
·
ESMO Real World Data and Digital Oncology
PDF
Double heterozygous pathogenic germline APC and MSH2 variants in a 16-year-old female diagnosed with colorectal cancer
2026
·
Elena Maccaroni
, Riccardo Bacalini
, et al.
·
Familial Cancer
PDF
Real-world comparative outcomes of first-line immune combinations (ICI–ICI vs ICI–TKI) in metastatic renal cell carcinoma with sarcomatoid features
2026
·
Sara Elena Rebuzzi
, Fabrizio Di Costanzo
, et al.
·
OncoImmunology
PDF
Dietary Calcium Intake in Patients Evaluated for Bone Fragility, with a Focus on Women Receiving Adjuvant Endocrine Therapy for Breast Cancer: A Single-Center Cross-Sectional Study
2026
·
Francesca Firmani
, Alessandro Ciarloni
, et al.
·
Nutrients
Prognostic Impact of Stage, Histology, and Treatment Strategy in 1.026 Thymic Epithelial Tumors: Report From Thetyme Registry
2026
·
M. Ganzinelli
, G. Lo Russo
, et al.
·
Journal of Thoracic Oncology
From fragmentation to focus: building collaborative networks for rare cancer research – the Italian TYME network as a model for care and innovation?
2026
·
Annalisa Trama
, Giuseppe Lo Russo
, et al.
·
Expert Review of Anticancer Therapy
Role and Characteristic of Multidisciplinarity in Hepatocellular Carcinoma Management and Care Pathway Certification: Bottom-Up Approach of the MDT Project in Italy
2026
·
Giuseppe Cabibbo
, Caterina Cocuzza
, et al.
·
Oncology and Therapy
PDF
[Epidemiological Analysis and Economic Burden of Gastric and Gastroesophageal Junction Neoplasms in Italy]
2026
·
Paolo Sciattella
, Angela Ragonese
, et al.
·
Farmeconomia Health economics and therapeutic pathways
PDF
Abstract PS2-06-12: Quantifying the Minimum Acceptable Benefit for a Novel Oral Adjuvant Therapy in HR+/HER2− Early Breast Cancer: A Probabilistic Threshold Technique Study in Italy
2026
·
A. Zambelli
, R. Berardi
, et al.
·
Clinical Cancer Research
Impact of heterozygous UGT1A1*28 genotype on toxicity, dose-intensity and treatment compliance in pancreatic cancer patients receiving FOLFIRINOX/mFOLFIRINOX.
2026
·
Riccardo Bacalini
, Pasqualina Castaldo
, et al.
·
Journal of Clinical Oncology
PDF
Oncological Genetic Counseling in Hereditary Breast and Ovarian Cancers and Lynch Syndrome High‐Risk Subjects: Evaluation of Efficacy and Outcomes Using the Genomics Outcome Scale
2026
·
Elena Maccaroni
, Rebecca Chiariotti
, et al.
·
Human Mutation
EP.11A.15 NSCLC-ClustOpt: A Semi-Supervised Optimized Clustering to Stratify Patients with NSCLC on Immune Checkpoint Blockers Therapy
2024
·
F. Paoloni
, F. Pecci
, et al.
·
Journal of Thoracic Oncology
PDF
Bone health and body composition in prostate cancer: Meet-URO and AIOM consensus about prevention and management strategies
2024
·
M. Di Maio
, A. Berruti
, et al.
·
Newcastle University ePrints (Newcastle Univesity)
66P Outcome predictors for pembrolizumab alone or with chemotherapy in advanced non-small cell lung cancer (NSCLC)
2023
·
L. Zullo
, E. Cella
, et al.
·
Journal of Thoracic Oncology
PDF
Show more works
View as search
Works count:
26
Citation count:
13
H-index:
2
I10-index:
Year
Topic
Type